Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DHG Pharmaceutical JSCSTC:DHG -1.37%80 EV-to-OCF is 14.77 as of Aug. 15, 2026, which is 9% below its 10-year median of 16.21. GuruFocus rates STC:DHG with a GF Score™ of 80/100 and a GF Value™ of ₫113,219.72 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,006 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks worse than 59.54% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, DHG Pharmaceutical JSC's Enterprise Value is ₫10,538,485 Mil.
DHG Pharmaceutical JSC's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was ₫713,299 Mil. Therefore, DHG Pharmaceutical JSC's EV-to-OCF for today is 14.77.
The historical rank and industry rank for DHG Pharmaceutical JSC's EV-to-OCF or its related term are showing as below:
STC:DHG'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.78 Med: 16.21 Max: 58.31
Current: 14.77
During the past 13 years, the highest EV-to-OCF of DHG Pharmaceutical JSC was 58.31. The lowest was 7.78. And the median was 16.21.
STC:DHG's EV-to-OCF is ranked worse than 59.54% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 11.045
vs STC:DHG: 14.77
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DHG Pharmaceutical JSC's PE Ratio (TTM) for today is calculated as:
DHG Pharmaceutical JSC's share price for today is ₫93600.00.
DHG Pharmaceutical JSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫7473.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's EV-to-OCF falls into.
DHG Pharmaceutical JSC's current Enterprise Value is ₫10,538,485 Mil.
DHG Pharmaceutical JSC's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫713,299 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a EV-to-OCF of 14.77 as of Aug. 15, 2026. This is near median its historical median of 16.21. Over the past decade, DHG Pharmaceutical JSC's EV-to-OCF has ranged from 7.78 to 58.31. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #599 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 59.5%.
Is DHG Pharmaceutical JSC's EV-to-OCF too high?
DHG Pharmaceutical JSC's current EV-to-OCF of 14.77 is near median its 10-year median of 16.21. Over the past 10 years, this metric has ranged from a low of 7.78 to a high of 58.31. The Drug Manufacturers industry median EV-to-OCF is 11.05. DHG Pharmaceutical JSC's value of 14.77 is 33.7% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #599 out of 1006 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, DHG Pharmaceutical JSC has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's EV-to-OCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #599 out of 1006 companies for EV-to-OCF. This places DHG Pharmaceutical JSC in the lower half of its industry. The industry median EV-to-OCF is 11.05. DHG Pharmaceutical JSC's value of 14.77 is 33.7% above this benchmark. Historically, DHG Pharmaceutical JSC's own EV-to-OCF has ranged from 7.78 to 58.31 over the past decade. While the company's 10-year median is 16.21 vs. the industry median of 11.05, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 11.05, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current EV-to-OCF of 14.77 is 33.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 11.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current EV-to-OCF is 14.77, which is near median its own 10-year median of 16.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,219.72, compared to a current price of ₫93,600.00 — trading 17.3% below its estimated fair value. The current EV-to-OCF is 14.77, which is near median its 10-year median of 16.21 and 33.7% above the Drug Manufacturers industry median of 11.05. DHG Pharmaceutical JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current EV-to-OCF is 14.77 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫93,600.00 is trading 17.3% below its estimated GF Value™ of ₫113,219.72.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
EV-to-OCF: 14.77 (near median its 10-year median of 16.21)
GF Value™: ₫113,219.72 vs. price of ₫93,600.00 (17.3% below fair value)
Industry Position: 33.7% above the Drug Manufacturers median (#599 of 1006)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
80GF Score
Get the complete analysis for STC:DHG
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
